HEADER TRANSFERASE/TRANSFERASE INHIBITOR 06-DEC-13 4NWM TITLE CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE TITLE 2 COMPLEXED WITH BMS-809959 AKA 4-TERT-BUTYL-N-[2-ME THYL-3-(6-{[4- TITLE 3 (MORPHOLINE-4-CARBONYL)PHENYL]AMINO}-9H- PURIN-2-YL)PHENYL]BENZAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 396-657; COMPND 5 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE, ATK, B-CELL PROGENITOR COMPND 6 KINASE, BPK, BRUTON TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: BACULOVIRUS KEYWDS KINASE, BTK, ATK, XLA, PSCTK1, AGMX1, AT, IMD1, MGC126261, MGC126262 KEYWDS 2 BPK, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.K.MUCKELBAUER REVDAT 3 22-NOV-17 4NWM 1 REMARK REVDAT 2 08-OCT-14 4NWM 1 JRNL REVDAT 1 02-APR-14 4NWM 0 JRNL AUTH Q.SHI,A.TEBBEN,A.J.DYCKMAN,H.LI,C.LIU,J.LIN,S.SPERGEL, JRNL AUTH 2 J.R.BURKE,K.W.MCINTYRE,G.C.OLINI,J.STRNAD,N.SURTI, JRNL AUTH 3 J.K.MUCKELBAUER,C.CHANG,Y.AN,L.CHENG,Q.RUAN,K.LEFTHERIS, JRNL AUTH 4 P.H.CARTER,J.TINO,G.V.DE LUCCA JRNL TITL PURINE DERIVATIVES AS POTENT BRUTON'S TYROSINE KINASE (BTK) JRNL TITL 2 INHIBITORS FOR AUTOIMMUNE DISEASES. JRNL REF BIOORG.MED.CHEM.LETT. V. 24 2206 2014 JRNL REFN ISSN 0960-894X JRNL PMID 24685542 JRNL DOI 10.1016/J.BMCL.2014.02.075 REMARK 2 REMARK 2 RESOLUTION. 2.03 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.03 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 3 NUMBER OF REFLECTIONS : 33555 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 1699 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 17 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.03 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.09 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.26 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2787 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1962 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2635 REMARK 3 BIN R VALUE (WORKING SET) : 0.1929 REMARK 3 BIN FREE R VALUE : 0.2546 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.45 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 152 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4064 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 88 REMARK 3 SOLVENT ATOMS : 182 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.32 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.67 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.79200 REMARK 3 B22 (A**2) : 0.91900 REMARK 3 B33 (A**2) : -5.71110 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.240 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.206 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.934 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.913 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4263 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5794 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1419 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 78 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 707 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4263 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 541 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5076 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.04 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.22 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.83 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4NWM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-DEC-13. REMARK 100 THE DEPOSITION ID IS D_1000083747. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-APR-08 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.25 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33694 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.020 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.02 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 7.00 REMARK 200 R MERGE FOR SHELL (I) : 0.07400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 28.10 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.25, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.45900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 67.56300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.25250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 67.56300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.45900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.25250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 489 REMARK 465 MET B 489 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 400 CG CD CE NZ REMARK 470 LYS A 406 CD CE NZ REMARK 470 GLU A 407 OE1 OE2 REMARK 470 LYS A 420 CD CE NZ REMARK 470 GLN A 424 CG CD OE1 NE2 REMARK 470 LYS A 433 NZ REMARK 470 GLU A 434 CG CD OE1 OE2 REMARK 470 ASP A 440 CG OD1 OD2 REMARK 470 GLU A 441 CD OE1 OE2 REMARK 470 GLU A 444 CG CD OE1 OE2 REMARK 470 GLU A 445 CG CD OE1 OE2 REMARK 470 LYS A 447 CG CD CE NZ REMARK 470 GLU A 455 CG CD OE1 OE2 REMARK 470 LYS A 466 CG CD CE NZ REMARK 470 ARG A 468 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 490 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 492 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 494 CD OE1 NE2 REMARK 470 LYS A 573 CG CD CE NZ REMARK 470 LYS A 595 CD CE NZ REMARK 470 GLU A 608 CG CD OE1 OE2 REMARK 470 GLN A 612 CG CD OE1 NE2 REMARK 470 GLU A 624 CD OE1 OE2 REMARK 470 LYS A 625 CD CE NZ REMARK 470 GLU A 636 CG CD OE1 OE2 REMARK 470 LYS A 637 CG CD CE NZ REMARK 470 ASP A 656 CG OD1 OD2 REMARK 470 GLU A 657 CG CD OE1 OE2 REMARK 470 LYS B 400 CG CD CE NZ REMARK 470 LYS B 406 CG CD CE NZ REMARK 470 LYS B 417 CE NZ REMARK 470 LYS B 420 CE NZ REMARK 470 GLN B 424 CG CD OE1 NE2 REMARK 470 TYR B 425 CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 433 CG CD CE NZ REMARK 470 GLU B 441 CD OE1 OE2 REMARK 470 GLU B 444 OE1 OE2 REMARK 470 GLU B 445 CG CD OE1 OE2 REMARK 470 LYS B 447 CG CD CE NZ REMARK 470 GLU B 455 CG CD OE1 OE2 REMARK 470 LYS B 466 CG CD CE NZ REMARK 470 GLN B 467 CG CD OE1 NE2 REMARK 470 ARG B 468 CD NE CZ NH1 NH2 REMARK 470 GLU B 488 CG CD OE1 OE2 REMARK 470 ARG B 490 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 492 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 494 CG CD OE1 NE2 REMARK 470 LYS B 503 CE NZ REMARK 470 LYS B 515 CE NZ REMARK 470 ASP B 549 CG OD1 OD2 REMARK 470 GLU B 550 CD OE1 OE2 REMARK 470 LYS B 573 CD CE NZ REMARK 470 LYS B 595 CD CE NZ REMARK 470 GLU B 608 CG CD OE1 OE2 REMARK 470 GLN B 612 CG CD OE1 NE2 REMARK 470 LEU B 614 CG CD1 CD2 REMARK 470 LYS B 625 CG CD CE NZ REMARK 470 GLU B 636 CG CD OE1 OE2 REMARK 470 LYS B 637 CG CD CE NZ REMARK 470 ASP B 639 OD1 OD2 REMARK 470 GLU B 640 CG CD OE1 OE2 REMARK 470 LYS B 645 CG CD CE NZ REMARK 470 ASP B 656 CG OD1 OD2 REMARK 470 GLU B 657 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 445 -7.20 178.00 REMARK 500 LYS A 466 35.10 -90.82 REMARK 500 ARG A 520 -11.35 81.81 REMARK 500 ASP A 521 50.60 -146.57 REMARK 500 ASP A 548 107.84 -170.91 REMARK 500 GLU B 445 -111.10 -78.81 REMARK 500 ALA B 446 -53.96 54.23 REMARK 500 ARG B 520 -12.84 83.89 REMARK 500 ASP B 521 51.33 -146.36 REMARK 500 ASP B 548 104.41 -170.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 2P5 A 701 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2P5 A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2P5 B 701 DBREF 4NWM A 396 657 UNP Q06187 BTK_HUMAN 396 657 DBREF 4NWM B 396 657 UNP Q06187 BTK_HUMAN 396 657 SEQADV 4NWM MET A 395 UNP Q06187 INITIATING METHIONINE SEQADV 4NWM MET B 395 UNP Q06187 INITIATING METHIONINE SEQRES 1 A 263 MET GLU ILE ASP PRO LYS ASP LEU THR PHE LEU LYS GLU SEQRES 2 A 263 LEU GLY THR GLY GLN PHE GLY VAL VAL LYS TYR GLY LYS SEQRES 3 A 263 TRP ARG GLY GLN TYR ASP VAL ALA ILE LYS MET ILE LYS SEQRES 4 A 263 GLU GLY SER MET SER GLU ASP GLU PHE ILE GLU GLU ALA SEQRES 5 A 263 LYS VAL MET MET ASN LEU SER HIS GLU LYS LEU VAL GLN SEQRES 6 A 263 LEU TYR GLY VAL CYS THR LYS GLN ARG PRO ILE PHE ILE SEQRES 7 A 263 ILE THR GLU TYR MET ALA ASN GLY OCS LEU LEU ASN TYR SEQRES 8 A 263 LEU ARG GLU MET ARG HIS ARG PHE GLN THR GLN GLN LEU SEQRES 9 A 263 LEU GLU MET CYS LYS ASP VAL CYS GLU ALA MET GLU TYR SEQRES 10 A 263 LEU GLU SER LYS GLN PHE LEU HIS ARG ASP LEU ALA ALA SEQRES 11 A 263 ARG ASN CYS LEU VAL ASN ASP GLN GLY VAL VAL LYS VAL SEQRES 12 A 263 SER ASP PHE GLY LEU SER ARG TYR VAL LEU ASP ASP GLU SEQRES 13 A 263 TYR THR SER SER VAL GLY SER LYS PHE PRO VAL ARG TRP SEQRES 14 A 263 SER PRO PRO GLU VAL LEU MET TYR SER LYS PHE SER SER SEQRES 15 A 263 LYS SER ASP ILE TRP ALA PHE GLY VAL LEU MET TRP GLU SEQRES 16 A 263 ILE TYR SER LEU GLY LYS MET PRO TYR GLU ARG PHE THR SEQRES 17 A 263 ASN SER GLU THR ALA GLU HIS ILE ALA GLN GLY LEU ARG SEQRES 18 A 263 LEU TYR ARG PRO HIS LEU ALA SER GLU LYS VAL TYR THR SEQRES 19 A 263 ILE MET TYR SER CYS TRP HIS GLU LYS ALA ASP GLU ARG SEQRES 20 A 263 PRO THR PHE LYS ILE LEU LEU SER ASN ILE LEU ASP VAL SEQRES 21 A 263 MET ASP GLU SEQRES 1 B 263 MET GLU ILE ASP PRO LYS ASP LEU THR PHE LEU LYS GLU SEQRES 2 B 263 LEU GLY THR GLY GLN PHE GLY VAL VAL LYS TYR GLY LYS SEQRES 3 B 263 TRP ARG GLY GLN TYR ASP VAL ALA ILE LYS MET ILE LYS SEQRES 4 B 263 GLU GLY SER MET SER GLU ASP GLU PHE ILE GLU GLU ALA SEQRES 5 B 263 LYS VAL MET MET ASN LEU SER HIS GLU LYS LEU VAL GLN SEQRES 6 B 263 LEU TYR GLY VAL CYS THR LYS GLN ARG PRO ILE PHE ILE SEQRES 7 B 263 ILE THR GLU TYR MET ALA ASN GLY OCS LEU LEU ASN TYR SEQRES 8 B 263 LEU ARG GLU MET ARG HIS ARG PHE GLN THR GLN GLN LEU SEQRES 9 B 263 LEU GLU MET CYS LYS ASP VAL CYS GLU ALA MET GLU TYR SEQRES 10 B 263 LEU GLU SER LYS GLN PHE LEU HIS ARG ASP LEU ALA ALA SEQRES 11 B 263 ARG ASN CYS LEU VAL ASN ASP GLN GLY VAL VAL LYS VAL SEQRES 12 B 263 SER ASP PHE GLY LEU SER ARG TYR VAL LEU ASP ASP GLU SEQRES 13 B 263 TYR THR SER SER VAL GLY SER LYS PHE PRO VAL ARG TRP SEQRES 14 B 263 SER PRO PRO GLU VAL LEU MET TYR SER LYS PHE SER SER SEQRES 15 B 263 LYS SER ASP ILE TRP ALA PHE GLY VAL LEU MET TRP GLU SEQRES 16 B 263 ILE TYR SER LEU GLY LYS MET PRO TYR GLU ARG PHE THR SEQRES 17 B 263 ASN SER GLU THR ALA GLU HIS ILE ALA GLN GLY LEU ARG SEQRES 18 B 263 LEU TYR ARG PRO HIS LEU ALA SER GLU LYS VAL TYR THR SEQRES 19 B 263 ILE MET TYR SER CYS TRP HIS GLU LYS ALA ASP GLU ARG SEQRES 20 B 263 PRO THR PHE LYS ILE LEU LEU SER ASN ILE LEU ASP VAL SEQRES 21 B 263 MET ASP GLU MODRES 4NWM OCS A 481 CYS CYSTEINESULFONIC ACID MODRES 4NWM OCS B 481 CYS CYSTEINESULFONIC ACID HET OCS A 481 9 HET OCS B 481 9 HET 2P5 A 701 44 HET 2P5 B 701 44 HETNAM OCS CYSTEINESULFONIC ACID HETNAM 2P5 4-TERT-BUTYL-N-[2-METHYL-3-(6-{[4-(MORPHOLIN-4- HETNAM 2 2P5 YLCARBONYL)PHENYL]AMINO}-7H-PURIN-2-YL) HETNAM 3 2P5 PHENYL]BENZAMIDE FORMUL 1 OCS 2(C3 H7 N O5 S) FORMUL 3 2P5 2(C34 H35 N7 O3) FORMUL 5 HOH *182(H2 O) HELIX 1 1 ASP A 398 LYS A 400 5 3 HELIX 2 2 SER A 438 GLU A 444 1 7 HELIX 3 3 GLU A 445 ASN A 451 1 7 HELIX 4 4 OCS A 481 GLU A 488 1 8 HELIX 5 5 GLN A 494 LYS A 515 1 22 HELIX 6 6 ALA A 523 ARG A 525 5 3 HELIX 7 7 GLY A 541 VAL A 546 5 6 HELIX 8 8 ASP A 548 SER A 553 1 6 HELIX 9 9 PRO A 560 SER A 564 5 5 HELIX 10 10 PRO A 565 SER A 572 1 8 HELIX 11 11 SER A 575 SER A 592 1 18 HELIX 12 12 THR A 602 GLY A 613 1 12 HELIX 13 13 SER A 623 CYS A 633 1 11 HELIX 14 14 LYS A 637 ARG A 641 5 5 HELIX 15 15 THR A 643 GLU A 657 1 15 HELIX 16 16 ASP B 398 LYS B 400 5 3 HELIX 17 17 SER B 438 GLU B 445 1 8 HELIX 18 18 ALA B 446 ASN B 451 1 6 HELIX 19 19 OCS B 481 GLU B 488 1 8 HELIX 20 20 GLN B 494 LYS B 515 1 22 HELIX 21 21 ALA B 523 ARG B 525 5 3 HELIX 22 22 GLY B 541 VAL B 546 5 6 HELIX 23 23 ASP B 548 SER B 553 1 6 HELIX 24 24 PRO B 560 SER B 564 5 5 HELIX 25 25 PRO B 565 SER B 572 1 8 HELIX 26 26 SER B 575 SER B 592 1 18 HELIX 27 27 THR B 602 GLY B 613 1 12 HELIX 28 28 SER B 623 CYS B 633 1 11 HELIX 29 29 LYS B 637 ARG B 641 5 5 HELIX 30 30 THR B 643 GLU B 657 1 15 SHEET 1 A 5 LEU A 402 GLY A 411 0 SHEET 2 A 5 GLY A 414 TRP A 421 -1 O VAL A 416 N LEU A 408 SHEET 3 A 5 TYR A 425 MET A 431 -1 O MET A 431 N VAL A 415 SHEET 4 A 5 PHE A 471 GLU A 475 -1 O ILE A 472 N LYS A 430 SHEET 5 A 5 LEU A 460 CYS A 464 -1 N GLY A 462 O ILE A 473 SHEET 1 B 2 CYS A 527 VAL A 529 0 SHEET 2 B 2 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528 SHEET 1 C 5 LEU B 402 GLY B 411 0 SHEET 2 C 5 GLY B 414 TRP B 421 -1 O TYR B 418 N LYS B 406 SHEET 3 C 5 TYR B 425 MET B 431 -1 O ILE B 429 N LYS B 417 SHEET 4 C 5 PHE B 471 GLU B 475 -1 O ILE B 472 N LYS B 430 SHEET 5 C 5 LEU B 460 CYS B 464 -1 N GLY B 462 O ILE B 473 SHEET 1 D 2 CYS B 527 VAL B 529 0 SHEET 2 D 2 VAL B 535 VAL B 537 -1 O LYS B 536 N LEU B 528 LINK C GLY A 480 N OCS A 481 1555 1555 1.34 LINK C OCS A 481 N LEU A 482 1555 1555 1.33 LINK C GLY B 480 N OCS B 481 1555 1555 1.34 LINK C OCS B 481 N LEU B 482 1555 1555 1.33 CISPEP 1 ARG A 468 PRO A 469 0 7.58 CISPEP 2 ARG B 468 PRO B 469 0 3.80 SITE 1 AC1 19 THR A 410 PHE A 413 VAL A 416 ALA A 428 SITE 2 AC1 19 LYS A 430 GLU A 475 MET A 477 ALA A 478 SITE 3 AC1 19 GLY A 480 ASN A 526 LEU A 528 ASP A 539 SITE 4 AC1 19 SER A 543 TYR A 551 HOH A 804 HOH A 824 SITE 5 AC1 19 HOH A 846 HOH A 865 HOH A 886 SITE 1 AC2 19 THR B 410 PHE B 413 VAL B 416 ALA B 428 SITE 2 AC2 19 LYS B 430 GLU B 475 MET B 477 ALA B 478 SITE 3 AC2 19 ASN B 479 GLY B 480 ASN B 526 LEU B 528 SITE 4 AC2 19 ASP B 539 SER B 543 TYR B 551 HOH B 814 SITE 5 AC2 19 HOH B 821 HOH B 847 HOH B 885 CRYST1 44.918 86.505 135.126 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022263 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011560 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007401 0.00000